Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 18 8 2020
medline: 11 11 2020
entrez: 18 8 2020
Statut: ppublish

Résumé

The coronavirus disease (COVID-19) pandemic is stressing healthcare services to an unprecedented extent. There is anecdotal evidence of reduction in organ donation and transplantation activity across the world. The weekly organ donation and liver transplant numbers over a 3-month period (Feb 17, 2020, till May 17, 2020) for the United States, United Kingdom, and India were compared with their previous year's activity. Liver transplant activity in 6 centers from these countries with varying local COVID-19 caseload was also compared. The COVID-19 pandemic has led to a significant contraction in organ donation and liver transplantation in all 3 countries. Peak reduction ranged from 25% in the United States to over 80% in the United Kingdom and India. The reduction was different for deceased donor and living donor liver transplantation and varied between centers within a country. There was early evidence of recovery of deceased donation in the United States and United Kingdom and resumption of living donor liver transplantation activity in India toward the end of the study period. A number of policy changes were undertaken at national and transplant center levels to ensure safe transplantation despite significant redirection of resources to combat the pandemic. There was a substantial reduction in organ donation and liver transplantation activity across the 3 countries with signs of recovery toward the end of the study period. Multiple factors including COVID-19 severity, stress on resources and influence of regulatory agencies and local factors are responsible for the reduction and recovery.

Sections du résumé

BACKGROUND
The coronavirus disease (COVID-19) pandemic is stressing healthcare services to an unprecedented extent. There is anecdotal evidence of reduction in organ donation and transplantation activity across the world.
METHODS
The weekly organ donation and liver transplant numbers over a 3-month period (Feb 17, 2020, till May 17, 2020) for the United States, United Kingdom, and India were compared with their previous year's activity. Liver transplant activity in 6 centers from these countries with varying local COVID-19 caseload was also compared.
RESULTS
The COVID-19 pandemic has led to a significant contraction in organ donation and liver transplantation in all 3 countries. Peak reduction ranged from 25% in the United States to over 80% in the United Kingdom and India. The reduction was different for deceased donor and living donor liver transplantation and varied between centers within a country. There was early evidence of recovery of deceased donation in the United States and United Kingdom and resumption of living donor liver transplantation activity in India toward the end of the study period. A number of policy changes were undertaken at national and transplant center levels to ensure safe transplantation despite significant redirection of resources to combat the pandemic.
CONCLUSIONS
There was a substantial reduction in organ donation and liver transplantation activity across the 3 countries with signs of recovery toward the end of the study period. Multiple factors including COVID-19 severity, stress on resources and influence of regulatory agencies and local factors are responsible for the reduction and recovery.

Identifiants

pubmed: 32804803
doi: 10.1097/TP.0000000000003416
pii: 00007890-202011000-00006
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2234-2243

Références

World Health Organization. Coronavirus disease (COVID-19) pandemic. Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed April 15, 2020
Royal College of Surgeons of England. COVID-19: good practice for surgeons and surgical teams. Available at https://www.rcseng.ac.uk/standards-and-research/standards-and-guidance/good-practice-guides/coronavirus/covid-19-good-practice-for-surgeons-and-surgical-teams/. Accessed April 13, 2020
American College of Surgeons. COVID-19: elective case triage guidelines for surgical care. Available at https://www.facs.org/covid-19/clinical-guidance/elective-case. Accessed April 13, 2020
Ahn C, Amer H, Anglicheau D, et al. Global transplantation COVID report March 2020. Transplantation. 2020. doi: 10.1097/TP.0000000000003258
doi: 10.1097/TP.0000000000003258
The Transplantation Society. Guidance on coronavirus disease 2019 (COVID-19) for transplant clinicians. Available at https://tts.org/23-tid/tid-news/657-tid-update-and-guidance-on-2019-novel-coronavirus-2019-ncov-for-transplant-id-clinicians. Accessed April 17, 2020
International Liver Transplantation Society. COVID-19 statement from the infectious diseases and liver transplantation SIG. Available at https://ilts.org/covid-19-statement-from-the-infectious-diseases-and-liver-transplantation-sig/. Accessed April 22, 2020
Fix OK, Hameed B, Fontana RJ, et al. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement. Hepatology. 2020; 72:287–304
WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. Available at https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed April 23, 2020
COVID-19: Advice for clinicians. ODT clinical: COVID-19: Clinical advice. NHS: Blood and transplant. Available at https://www.odt.nhs.uk/covid-19-advice-for-clinicians/. Accessed April 23, 2020
NOTTO: National Organ & Tissue Transplant Organization. News & events. Available at https://notto.gov.in/news-events.htm. Accessed April 23, 2020
UNOS: United Network for Organ Sharing. COVID-19 and solid organ transplant. Available at https://UNOS.org/COVID. Accessed April 23, 2020
Government of Tamilnadu. TRANSTAN-Transplant Authority of Tamil Nadu. Available at https://transtan.tn.gov.in/. Accessed April 20, 2020
CDC: Centers for Disease Control and Prevention. Coronavirus disease: Cases in the US. 2020. Available at https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed April 23, 2020
Coronavirus cases in the UK: daily updated statistics. Gov.uk website. Available at https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public. Accessed May 23, 2020
Government of India issues orders prescribing lockdown for containment of COVID-19 epidemic in the country. Available at https://pib.gov.in/newsite/. Accessed April 15, 2020
Saigal S, Gupta S, Sudhindran S, et al. Liver transplantation and COVID-19 (coronavirus) infection: guidelines of the Liver Transplant Society of India (LTSI). Hepatol Int. 20201–3. doi:10.1007/s12072-020-10041-1
doi: 10.1007/s12072-020-10041-1
Chowell G, Mizumoto K. The COVID-19 pandemic in the USA: what might we expect? Lancet. 2020; 395:1093–1094
Kinross P, Suetens C, Gomes Dias J, et al. Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020. Euro Surveill. 2020; 25:2000285. doi:10.2807/1560-7917.ES.2020.25.11.2000285
doi: 10.2807/1560-7917.ES.2020.25.11.2000285
Kumar D, Humar A. CMV immune monitoring-where do we go from here? Am J Transplant. 2020; 20:1961–1962
Loupy A, Aubert O, Reese PP, et al. Organ procurement and transplantation during the COVID-19 pandemic. Lancet. 2020; 395:e95–e96
Angelico R, Trapani S, Manzia TM, et al. The COVID-19 outbreak in Italy: initial implications for organ transplantation programs. Am J Transplant. 2020; 20:1780–1784
Prin M, Wunsch H. International comparisons of intensive care: informing outcomes and improving standards. Curr Opin Crit Care. 2012; 18:700–706
Niall McCarthy. The countries with the most critical care beds per capita. Statista Infographics. 2020. Available at https://www.statista.com/chart/21105/number-of-critical-care-beds-per-100000-inhabitants/. Accessed April 15, 2020
Wall AE, Pruett T, Stock P, et al. Coronavirus disease 2019: utilizing an ethical framework for rationing absolutely scarce health-care resources in transplant allocation decisions. Am J Transplant. 2020. doi:10.1111/ajt.15914
doi: 10.1111/ajt.15914

Auteurs

Mettu S Reddy (MS)

Liver Transplant Unit, Dr Rela Institute & Medical Center, Chennai, India.

Abdul R Hakeem (AR)

Liver Transplant Unit, Dr Rela Institute & Medical Center, Chennai, India.

Tarunjeet Klair (T)

Liver Transplant Unit, University of Texas Health San Antonio, San Antonio, TX.

Francesca Marcon (F)

Liver Transplant Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Abhishek Mathur (A)

Liver Transplant Unit, New York Presbyterian-Columbia University Medical Center, New York, NY.

Benjamin Samstein (B)

Liver Transplant Unit, New York Presbyterian-Weill Cornell Medical Center, New York, NY.

Ravi Mohanka (R)

Liver Transplant Unit, Global Hospitals, Mumbai, India.
Zonal Transplant Coordination Center, Mumbai, India.

Surendra K Mathur (SK)

Zonal Transplant Coordination Center, Mumbai, India.

Andreas Prachalias (A)

Liver Transplant Unit, Kings College & Hospital, London, United Kingdom.

Krishna V Menon (KV)

Liver Transplant Unit, Kings College & Hospital, London, United Kingdom.

Paolo Muiesan (P)

Liver Transplant Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Mohamed Rela (M)

Liver Transplant Unit, Dr Rela Institute & Medical Center, Chennai, India.

Jean C Emond (JC)

Liver Transplant Unit, New York Presbyterian-Columbia University Medical Center, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH